Mesalamine-induced myocarditis
- PMID: 20871830
- PMCID: PMC2943131
- DOI: 10.4061/2010/930190
Mesalamine-induced myocarditis
Abstract
Nowadays mesalamine is a common treatment for Crohn's disease and hypersensitive reactions to this product have been reported. Yet there is limited information concerning mesalamine-induced myocarditis and its mechanism is not known. We described a case of mesalamine-induced myocarditis in Crohn's disease of the colon.
Figures


References
-
- García-Ferrer L, Estornell J, Palanca V. Myocarditis by mesalazine with cardiac magnetic resonance imaging. European Heart Journal. 2009;30(8):p. 1015. - PubMed
-
- Doganay L, Akinci B, Pekel N, Simsek I, Akpinar H. Mesalazine-induced myopericarditis in a patient with ulcerative colitis. International Journal of Colorectal Disease. 2006;21(2):199–200. - PubMed
-
- Stelts S, Taylor MH, Nappi J, Van Bakel AB. Mesalamine-associated hypersensitivity myocarditis in ulcerative colitis. Annals of Pharmacotherapy. 2008;42(6):904–905. - PubMed
-
- Kirstensen KS, Høegholm A, Bohr L, Friis S. Fatal myocarditis associated with mesalazine. Lancet. 1990;335(8689):p. 605. - PubMed
-
- García-Morán S, Sáez-Royuela F, Pérez-Alvarez J-C, Gento E, Téllez J. Myopericarditis and mitral insufficiency associated with ulcerative colitis treated with mesalazine. Inflammatory Bowel Diseases. 2006;12(4):334–335. - PubMed
Publication types
LinkOut - more resources
Full Text Sources